Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-28T18:48:51.739Z Has data issue: false hasContentIssue false
  • English
  • Français

Deterioration in renal function following commencement of citalopram

Published online by Cambridge University Press:  13 June 2014

Neil Mayfield ,
Kay Anderson  and
Colin Rodger
Neil Mayfield
Affiliation:
Royal Edinburgh Hospital, Edinburgh
Kay Anderson
Affiliation:
Royal Victoria Hospital, Edinburgh
Colin Rodger
Affiliation:
Herdmanflat Hospital, Haddington, East Lothian, England
Get access Rights & Permissions [Opens in a new window]

Abstract

We report the case of an 85 year old woman, admitted to hospital with a two month history of a depressive illness. Within one week of commencing treatment with citalopram 20mg daily, she had developed a widespread rash, bilateral ankle oedema and a range of biochemical and haematological abnormalities, including marked elevations of plasma urea and creatinine and increased neutrophil and eosinophil counts. Following withdrawal of citalopram, her physical state returned to normal within two weeks. The episode is suggestive of acute interstitial nephritis triggered by citalopram, a phenomenon not previously reported in association with the selective serotonin reuptake inhibitors.

Type
Case report
Information
Irish Journal of Psychological Medicine , Volume 20 , Issue 1 , March 2003 , pp. 32 - 33
Copyright
Copyright © Cambridge University Press 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Toto, RD. Acute tubulointerstitial nephritis. Am J Med Sci 1990; 299: 392–410.CrossRefGoogle ScholarPubMed
2.Elias, TJ, Bannister, KM, Clarkson, AR, Faull, D, Faull, RJ. Clozapine-induced acute interstitial nephritis. Lancet 1999; 354: 1180–1181.CrossRefGoogle ScholarPubMed
3.Greenberg, A. Diuretic complications. Am J Med Sci 2000; 319: 10–24.CrossRefGoogle ScholarPubMed
4.Stockley, IH. Drug Interactions. London: Pharmaceutical Press 1999.Google Scholar
5.Joyce, PR, Hawes, CR, Mulder, RT, Sellman, JD, Wilson, DA, Boswell, DR. Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 1992; 32: 1035–1041.CrossRefGoogle ScholarPubMed